INVA (STOCKS)
Innoviva, Inc. Common Stock
$22.420000
-0.320000 (-1.41%)
Prev close: $22.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pavel Raifeld
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,655.53M
- Employees
- 127
- P/E (TTM)
- 3.78
- P/B (TTM)
- 1.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.05 | $0.40 | -0.4478 | -112.57% |
|
Dec 2025 (Q4)
|
$1.94 | $0.56 | +1.3790 | +245.81% |
|
Sep 2025 (Q3)
|
$1.08 | $0.49 | +0.5878 | +119.42% |
|
Jun 2025 (Q2)
|
$0.77 | $0.51 | +0.2600 | +50.98% |
Financial Statements
| Revenues | $420.69M |
| Benefits Costs and Expenses | -$179.32M |
| Cost Of Revenue | $110.51M |
| Costs And Expenses | -$179.32M |
| Gross Profit | $310.19M |
| Operating Expenses | $149.71M |
| Selling, General, and Administrative Expenses | $118.27M |
| Research and Development | $31.45M |
| Operating Income/Loss | $160.47M |
| Income/Loss Before Equity Method Investments | $287.38M |
| Income/Loss From Continuing Operations After Tax | $504.34M |
| Income/Loss From Continuing Operations Before Tax | $600.01M |
| Income/Loss From Equity Method Investments | $312.63M |
| Income Tax Expense/Benefit | $95.67M |
| Income Tax Expense/Benefit, Deferred | $85.13M |
| Interest And Dividend Income, Operating | $27.54M |
| Interest Expense, Operating | $17.42M |
| Net Income/Loss | $504.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $504.34M |
| Net Income/Loss Available To Common Stockholders, Basic | $504.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $7.20 |
| Diluted Earnings Per Share | $6.02 |
| Basic Average Shares | 208,577,000 |
| Diluted Average Shares | 254,449,000 |
| Assets | $1.84B |
| Current Assets | $772.62M |
| Inventory | $38.84M |
| Other Current Assets | $733.78M |
| Noncurrent Assets | $1.06B |
| Fixed Assets | $2.14M |
| Intangible Assets | $175.60M |
| Other Non-current Assets | $886.22M |
| Liabilities | $494.93M |
| Current Liabilities | $36.56M |
| Accounts Payable | $6.52M |
| Wages | $4.33M |
| Other Current Liabilities | $25.71M |
| Noncurrent Liabilities | $458.37M |
| Equity | $1.34B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.34B |
| Liabilities And Equity | $1.84B |
| Net Cash Flow From Operating Activities | $183.60M |
| Net Cash Flow From Operating Activities, Continuing | $183.60M |
| Net Cash Flow From Investing Activities | $112.18M |
| Net Cash Flow From Investing Activities, Continuing | $112.18M |
| Net Cash Flow From Financing Activities | -$11.78M |
| Net Cash Flow From Financing Activities, Continuing | -$11.78M |
| Net Cash Flow | $284.00M |
| Net Cash Flow, Continuing | $284.00M |
| Comprehensive Income/Loss | $504.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $504.34M |
| Other Comprehensive Income/Loss | $0.00 |